Tau mutant A152T, a risk factor for FTD/PSP, induces neuronal dysfunction and reduced lifespan independently of aggregation in a C. elegans Tauopathy model-Reference-Cited by-同舟云学术

Tau mutant A152T, a risk factor for FTD/PSP, induces neuronal dysfunction and reduced lifespan independently of aggregation in a C. elegans Tauopathy model

Published:2016-04-27 Issue:1 Volume:11 Page:
ISSN:1750-1326
Container-title:Molecular Neurodegeneration
language:en
Short-container-title:Mol Neurodegeneration

Author:

Pir Ghulam Jeelani,Choudhary Bikash,Mandelkow Eckhard,Mandelkow Eva-Maria

Funder

Deutsches Zentrum für Neurodegenerative Erkrankungen

Max-Planck-Institut Society

Max-Planck Society

Tau Consortium

Wellcome Trust/MRC Consortium

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology (clinical),Molecular Biology

Link

http://link.springer.com/content/pdf/10.1186/s13024-016-0096-1

Reference79 articles.

1. Goedert M, Crowther RA, Spillantini MG. Tau mutations cause frontotemporal dementias. Neuron. 1998;21(5):955–8.

2. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A. 1986;83(13):4913–7.

3. Mandelkow EM, Mandelkow E. Biochemistry and cell biology of tau protein in neurofibrillary degeneration. Cold Spring Harb Perspect Med. 2012;2(7):a006247. doi: 10.1101/cshperspect.a006247 .

4. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick’s Disease. Arch Neurol. 2001;58(11):1803–9.

5. von Bergen M, Barghorn S, Biernat J, Mandelkow EM, Mandelkow E. Tau aggregation is driven by a transition from random coil to beta sheet structure. Biochim Biophys Acta. 2005;1739(2-3):158–66.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling immunoglobulin light chain amyloidosis inCaenorhabditis elegans;2024-07-09

2. C. elegans : a prominent platform for modeling and drug screening in neurological disorders;Expert Opinion on Drug Discovery;2024-03-20

3. Towards Understanding Neurodegenerative Diseases: Insights from Caenorhabditis elegans;International Journal of Molecular Sciences;2023-12-28

4. Caenorhabditis elegans as a Model System to Study Human Neurodegenerative Disorders;Biomolecules;2023-03-05

5. All the Tau We Cannot See;Annual Review of Medicine;2023-01-27